A long-term, open-label, safety extension study of the combination of Fenofibric Acid and statin therapy for subjects with mixed dyslipidemia
Phase of Trial: Phase III
Latest Information Update: 28 Jul 2009
At a glance
- Drugs Atorvastatin; Choline fenofibrate; Rosuvastatin; Simvastatin
- Indications Dyslipidaemias
- Focus Adverse reactions; Registrational
- Sponsors Abbott Laboratories
- 31 Aug 2018 Biomarkers information updated
- 28 Jul 2009 Actual patient number (1911) added as reported by ClinicalTrials.gov.
- 12 Jun 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.